Conor McNamara
Stock Analyst at RBC Capital
(0.97)
# 3,758
Out of 4,944 analysts
136
Total ratings
27%
Success rate
-18.49%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $2.76 | +81.16% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $157.66 | +61.74% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $2.08 | +44.23% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $43.41 | +5.97% | 1 | Aug 7, 2025 | |
| TECH Bio-Techne | Maintains: Sector Perform | $63 → $61 | $53.72 | +13.55% | 10 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $68.35 | +27.29% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $12.75 | +33.33% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $99.48 | +26.66% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $280.35 | +45.89% | 12 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $271.71 | +50.53% | 12 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $123.64 | +65.00% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $481.95 | +32.17% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $207.41 | +20.53% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $26.05 | +134.17% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $3.15 | +122.22% | 4 | Aug 7, 2024 |
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $2.76
Upside: +81.16%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $157.66
Upside: +61.74%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $2.08
Upside: +44.23%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $43.41
Upside: +5.97%
Bio-Techne
Aug 7, 2025
Maintains: Sector Perform
Price Target: $63 → $61
Current: $53.72
Upside: +13.55%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $68.35
Upside: +27.29%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $12.75
Upside: +33.33%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $99.48
Upside: +26.66%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $280.35
Upside: +45.89%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $271.71
Upside: +50.53%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $123.64
Upside: +65.00%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $481.95
Upside: +32.17%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $207.41
Upside: +20.53%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $26.05
Upside: +134.17%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $3.15
Upside: +122.22%